These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32347057)

  • 21. Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin.
    Lee WR; Shen SC; Zhuo RZ; Wang KC; Fang JY
    Hum Gene Ther; 2009 Jun; 20(6):580-8. PubMed ID: 19239381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivering siRNA with Dendrimers: In Vivo Applications.
    Leiro V; Santos SD; Pego AP
    Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient and targeted delivery of siRNA in vivo.
    Shim MS; Kwon YJ
    FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Int J Pharm; 2018 May; 542(1-2):213-220. PubMed ID: 29551748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
    Gooding M; Browne LP; Quinteiro FM; Selwood DL
    Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector.
    Tekade RK; Maheshwari RG; Sharma PA; Tekade M; Chauhan AS
    Curr Pharm Des; 2015; 21(31):4614-36. PubMed ID: 26486147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Molecules; 2016 Sep; 21(10):. PubMed ID: 27669207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
    Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
    Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
    Zhao J; Feng SS
    Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymers in the Delivery of siRNA for the Treatment of Virus Infections.
    Reynolds N; Dearnley M; Hinton TM
    Top Curr Chem (Cham); 2017 Apr; 375(2):38. PubMed ID: 28324594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Theoretical Study on Inhibition of Melanoma with Controlled and Targeted Delivery of siRNA via Skin Using SPACE-EGF.
    Liu J; Ding W; Ruan R; Zou L; Chen M; Wei P; Wen L
    Ann Biomed Eng; 2017 Jun; 45(6):1407-1419. PubMed ID: 28349327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Powering up the molecular therapy of RNA interference by novel nanoparticles.
    Liao W; Li W; Zhang T; Kirberger M; Liu J; Wang P; Chen W; Wang Y
    Biomater Sci; 2016 Jun; 4(7):1051-61. PubMed ID: 27221980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro.
    Xu XL; Yang HY; Ou B; Lin SD; Wu H; He W; Jiang QC; Luo BM; Li GP
    Int J Oncol; 2015 May; 46(5):2138-42. PubMed ID: 25760143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
    Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
    Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal siRNA delivery by pH-switchable micelles with targeting effect suppress skin melanoma progression.
    Wang MZ; Niu J; Ma HJ; Dad HA; Shao HT; Yuan TJ; Peng LH
    J Control Release; 2020 Jun; 322():95-107. PubMed ID: 32194172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.